Pfizer Global Medical Grants Inflammatory Bowel Disease RFP
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: inquire with unit
Memorial Deadline: Monday 27th, June 2022
External Deadline: Thursday 30th, June 2022
Description
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest, sets timelines for review and approval, and uses an expert review panel (ERP). Institutions are invited to submit an application as outlined in the specific RFP.
This RFP reflects Pfizer’s commitment to advancing research, innovation, and training for medical, nursing, and allied health professionals.
Geographic Scope: Europe, Canada, Australia, New Zealand, Japan, Israel and Turkey
Clinical Area: Inflammatory Bowel Disease
Link to full RFP: Inflammatory Bowel Disease
Application Due Date: June 30, 2022
Specific Area of Interest: Through this grant programme, we intend to support research and clinical training fellowship programmes in regions where there are continued workforce challenges in relation to the management of IBD patients.
Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to the Grant Officer, Ai Ping Lee (AiPing.Lee@pfizer.com).